Anti-Klebsiella sheep monoclonal antibody - KS Biomedix Holdings
Latest Information Update: 14 May 2001
At a glance
- Originator KS Biomedix Holdings
- Class Antibacterials; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Klebsiella infections
Most Recent Events
- 14 May 2001 Discontinued-Preclinical for Klebsiella infections in United Kingdom (Unknown route)
- 18 Oct 2000 The product is available for licensing (http://www.ksbiomedix.com)
- 17 Dec 1997 Preclinical development for Klebsiella infections in United Kingdom (Unknown route)